Management of impairment, disability, and handicap due to multiple sclerosis

Kathryn A. Stolp-Smith, Jonathan L. Carter, Daniel E. Rohe, Daniel P. Knowland

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

In this article, we update management measures for patients with multiple sclerosis (MS) that can improve or prevent impairment, disability, and handicap and include those factors that a primary-care physician can implement or facilitate. The medical literature since 1989 was reviewed. Although new drug trials hold promise to decrease impairment from MS, well- coordinated interdisciplinary care to minimize disability and handicap most profoundly affect the quality of life for patients with MS, MS is usually not severely disabling, and appropriately timed intervention can prevent secondary impairment and reduce disability and handicap. Pharmacologic, physical, and psychosocial issues-ranging from spasticity, pain, weakness, and tremor to neurogenic bowel management and sexuality-are addressed. General wellness measures remain important. The influence of the Americans With Disabilities Act is discussed, and specific adaptive equipment and social resources are outlined. The ultimate goals of management of patients with MS are functional independence and efficient use of medical and community resources: a focus on 'ability' rather than 'disability.' Although impairment can limit function, wellness and adjustment have no boundaries.

Original languageEnglish (US)
Pages (from-to)1184-1195
Number of pages12
JournalMayo Clinic proceedings
Volume72
Issue number12
DOIs
StatePublished - Jan 1 1997

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Management of impairment, disability, and handicap due to multiple sclerosis'. Together they form a unique fingerprint.

Cite this